HUM-MOLGEN archive: HUM-MOLGEN News Alert

__________________________________________________________________________ CHI’s 13th International Molecular Medicine Tri-Conference Moscone North Convention Center | San Francisco, California February 21-24, 2006 - http://hum-molgen.org/promotion-tri Cambridge Healthtech Institute’s 13th International Molecular Medicine Tri-Conference is the most comprehensive, rapidly growing, and exciting drug discovery and development forum worldwide. __________________________________________________________________________ INTERNATIONAL COMMUNICATION FORUM IN HUMAN MOLECULAR GENETICS HUM-MOLGEN News Alert - January 18, 2005 - http://hum-molgen.org Genetic News by T.M. D'Souza, S. Chandler, T. Dalaya, K. Markey, J. Mill, La Merie S.L, R. Nemade, D. Sharma, F.S. Zollmann http://hum-molgen.org/NewsGen - Tight race to be the first in a new class of dipeptidyl peptidase IV (DPP-IV) inhibitors for the oral treatment of type 2 diabetes New oral treatment modality for type 2 diabetes. http://hum-molgen.org/NewsGen/01-2006/msg18.html - Cracking The Genetic Code For Control Of Gene Expression Genome-wide Prediction of Mammalian Enhancers Based on Analysis of Transcription-Factor Binding Affinity http://hum-molgen.org/NewsGen/01-2006/msg17.html - deCODE Discovers Major Genetic Risk Factor for Type 2 Diabetes Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes http://hum-molgen.org/NewsGen/01-2006/msg16.html - Retinopathy: Ribozymes, Receptors and Really tight junctions Increased blood sugar leads to vascular permeability, increased VEGF pathway expression and induction of angiogenesis. New research pinpoints the main players in this process and highlights therapeutic avenues for intervention. http://hum-molgen.org/NewsGen/01-2006/msg15.html - Relation Between Increased Fetal Nuchal Translucency Thickness and Chromosomal Defects. The prevalence and distribution of all chromosomal defects in fetuses with increased nuchal translucency thickness were examined. http://hum-molgen.org/NewsGen/01-2006/msg14.html - Brain Cholesterol Metabolism And Alzheimer’s Disease Regulating cholesterol levels in the brain decreases levels of the Amyloid-beta peptide which is thought to be the causative agent involved in the pathology of Alzheimer's disease. http://hum-molgen.org/NewsGen/01-2006/msg13.html - Grammar For Proteins Grammatical rules can be applied to describe the functions of proteins. http://hum-molgen.org/NewsGen/01-2006/msg12.html - Novel Mutation Could Improve Response To Therapy Scientists report a novel mutation in the epidermal growth factor receptor (EGFR) gene that could change the way that EGFR targeted therapies are given to patients with non-small-cell lung cancer. http://hum-molgen.org/NewsGen/01-2006/msg11.html - Fighting The Fat The level of a simple substance in a small brain region may act as a crucial signal in the regulation of body weight. http://hum-molgen.org/NewsGen/01-2006/msg10.html - Determining Brain Gender Scientist explain the function of a protein called alpha-fetoprotein (AFP) which binds to and regulates gender-determining estrogen during fetal development. http://hum-molgen.org/NewsGen/01-2006/msg09.html - Why Infections Sometimes Suppress Immunity New light is shed on the mechanisms of infection-induced immunosuppression. http://hum-molgen.org/NewsGen/01-2006/msg08.html - Targeting Leukemia Report of a new inhibitor of Bcr-abl kinase, a key therapeutic target for treating chronic myelogenous leukemia (CML). http://hum-molgen.org/NewsGen/01-2006/msg07.html - Sneaking Into DNA Two anti-tumor agents are able to modify DNA, even when it is all bound up inside cells. http://hum-molgen.org/NewsGen/01-2006/msg06.html - Why the Brain Has "Gray Matter" Interdisciplinary approach attempts to explain structural differences of the central nervous system. http://hum-molgen.org/NewsGen/01-2006/msg05.html - The Air You Breathe Might Contribute to Atherosclerosis Air pollution and a high fat diet are found to be contributing factors in the development of Atherosclerosis. http://hum-molgen.org/NewsGen/01-2006/msg03.html - Tight Glucose Control Cuts Heart Disease by Half in Diabetic Patients Glucose control is better than taking drugs in preventing cardiovascular events in Type 1 Diabetic patients. http://hum-molgen.org/NewsGen/01-2006/msg02.html - Combined Techniques Strengthen Alzheimer's Disease Detection Brain imaging combined with beta-amyloid measurements advances detection. http://hum-molgen.org/NewsGen/01-2006/msg01.html - Contact Genetic News editors WWW: http://hum-molgen.org/editors.html E-mail: news@hum-molgen.org DIAGnostics - Clinical Research (professional requests) http://hum-molgen.org/clinical-research/ - Post diagnostic request / call for collaboration http://hum-molgen.org/diagnostic-posting or contact admin@hum-molgen.org Biotechnical requests and sources http://hum-molgen.org/biotechnology Biomedical Positions http://hum-molgen.org/positions/ - Genetics: post-doctoral fellow CNRS, Lille, 59021, France http://hum-molgen.org/positions/postdocs/2609.html - Call for Assistant News Editors To further strengthen our news section we are currently looking for: Assistant Editors for the HUM-MOLGEN News section http://hum-molgen.org/NewsGen/04-2003/msg01.html - Write a position announcement http://hum-molgen.org/flyer/positions.pdf 1) Set up account: http://hum-molgen.de/cgi-bin/positions.pl?register 2) Post position(s): http://hum-molgen.de/cgi-bin/positions.pl?login Literature http://hum-molgen.org/literature/ - Knäblein, Jörg (ed.). 2005. Modern Biopharmaceuticals Design, Development and Optimization http://hum-molgen.org/literature/01-2006/msg02.html - Edwards. 2006. The Nanotech Pioneers Where Are They Taking Us? http://hum-molgen.org/literature/01-2006/msg01.html Events in bioscience and medicine http://hum-molgen.org/meetings/ - Post event (free) http://hum-molgen.de/cgi-bin/meetings.pl?login Registry of Biomedical Companies (1262 active entries) http://hum-molgen.org/companies/ Mailing List Administration (Join or leave the list) http://hum-molgen.org/subscribe-na/ Feedback contact admin@hum-molgen.org Advertise at HUM-MOLGEN http://hum-molgen.org/flyer/advertise.pdf contact FS Zollmann (dialogue@hum-molgen.org) __________________________________________________________________________ CHI’s 13th International Molecular Medicine Tri-Conference Moscone North Convention Center | San Francisco, California February 21-24, 2006 - http://hum-molgen.org/promotion-tri Cambridge Healthtech Institute’s 13th International Molecular Medicine Tri-Conference is the most comprehensive, rapidly growing, and exciting drug discovery and development forum worldwide. This years event will be held February 21-24, 2006 in San Francisco, CA. Over 2,000 pharmaceutical, diagnostic, biotech, academic, government researchers and industry leaders will convene to discuss innovative trends and approaches, and present the latest results. The Molecular Medicine Tri-conference will feature 40 of the hottest emerging biotech companies in a partnering forum, followed by six concurrent tracks on Pathway Analysis for Target and Compound Evaluation; R&D Strategies Executive Summit; Mastering Medicinal Chemistry; Preclinical Development; Molecular Diagnostics; and new this year, Commercial Implications of Stem Cell Research. __________________________________________________________________________